Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Virginia |
---|---|
Information provided by: | University of Virginia |
ClinicalTrials.gov Identifier: | NCT00315939 |
The purpose of this study is to test two newly developed computer programs, IBMF-1 and IBMF-2. The computer programs are considered experimental. Both computer programs are being tested to see if they are useful in helping people with type 1 diabetes avoid low blood sugar episodes.
Condition | Intervention |
---|---|
Diabetes Mellitus, Type 1 |
Device: 2 computer programs - IBMF-1 and IBMF-2 |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Non-Randomized, Open Label, Crossover Assignment |
Official Title: | Improving Metabolic Control and Reducing Hypoglycemic Risk in Type 1 Diabetes Mellitus With Biological and Behavioral Feedback |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Pam Mendosa, RN | 434-982-6481 | pcm9b@virginia.edu |
United States, Virginia | |
University of Virginia - Behavioral Medicine Research Center | Recruiting |
Charlottesville, Virginia, United States, 22908 | |
Principal Investigator: Boris Kovatchev, Ph.D. |
Principal Investigator: | Boris Kovatchev, Ph.D. | University of Virginia, Department of Psychiatric Medicine, Behavioral Medicine Research |
Study ID Numbers: | RO1 DK 51562 - 12126 |
Study First Received: | April 18, 2006 |
Last Updated: | April 20, 2006 |
ClinicalTrials.gov Identifier: | NCT00315939 History of Changes |
Health Authority: | United States: Institutional Review Board |
Diabetes hypoglycemic episodes |
Hypoglycemic Agents Autoimmune Diseases Metabolic Diseases Diabetes Mellitus, Type 1 Diabetes Mellitus |
Endocrine System Diseases Diabetes Mellitus Type 1 Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Hypoglycemic Agents Autoimmune Diseases Metabolic Diseases Immune System Diseases Diabetes Mellitus, Type 1 |
Physiological Effects of Drugs Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Pharmacologic Actions |